Possible impact of impaired double-stranded rna degradation and nitrosative stress on immuno-inflammatory cascade in type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 9, 2009, Pages 480-485

  Kocic, G M ^a   Kocic, R ^a   Pavlovic, R ^b   Jevtovic Stoimenov, T ^a   Sokolovic, D ^a   Nikolic, G ^b   Pavlovic, V ^a   Stojanovic, S ^a   Basic, J ^a   Veljkovic, A ^a   Pavlovic, D ^a   Kamenov, B ^a  

^a Medical Faculty   (Serbia)

^b Medical Faculty Nis   (Serbia)

Author keywords

Bax; Bcl 2; Carbonyl groups; Circulating nucleic acids (CNAs) xanthine oxidase (XO); IRF 3; MDA 5; NF .B; Nitric oxide (NO); Rnase; Type 2 diabetes

Indexed keywords

3 NITROTYROSINE; FRUCTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; NITRATE; NITRITE; PROTEIN BAX; PROTEIN BCL 2; RNA; XANTHINE OXIDASE;

ADULT; AGED; ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE STRANDED RNA DEGRADATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FRUCTOSAMINE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MALE; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; RNA DEGRADATION; RNA METABOLISM; THYMOCYTE; UPREGULATION;

ADULT; AGED; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOOD GLUCOSE; CELLS, CULTURED; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 2; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; MALE; MIDDLE AGED; NF-KAPPA B; NITRITES; NUCLEIC ACIDS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA STABILITY; RNA, DOUBLE-STRANDED; THYMUS GLAND; TYROSINE; XANTHINE OXIDASE;

EID: 71049172064     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1202830     Document Type: Article

References (55)

1. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 2007 65 S152-156
2. Duncan BB, Schmidt MI, Pankow JS, et al. Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes. Diabetes 2003 52 1799-1805
3. Tsan MF, Gao B. Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J Endotox Res 2007 13 (1) 6-14
4. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a DAMP view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007 3 (7) 382-390
5. Lotze MT, Zeh HJ, Rubartelli A, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007 220 (1) 60-81
6. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology 2007 28 (10) 429-436
7. Suzuki K, Mori A, Ishi KJ, et al. Activation of target tissue immune recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci USA 1999 96 2285-2290
8. Devendra D, Jasinski J, Melanitou E, et al. Interferon- as a Mediator of Polyinosinic:polycytidylic acidinduced type 1 diabetes. Diabetes 2005 54 2549-2556
9. Doukas J, Cutler AH, Mordes JP. Polyinosinic:polycytidylic acid is a potent activator of endothelial cells. Am J Pathol 1994 145 137-147
10. Faruqi TR, DiCorleto PE. IFN-gamma inhibits double-stranded RNA-induced E-selectin expression in human endothelial cells. J Immunol 1997 159 3989-3994
11. Moriyama H, Wen L, Abiru N, et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidilyc acid) and jan insulin sellf-peptide. Proc Natl Acad Sci 2002 99 5539-5544
12. Rhodes CJ, Taylor KW. Effect of interferon and double-stranded RNA on ß-cell function in mouse islets of Langerhans. Biochem J 1985 228 87-94
13. Heitmeier MR, Scarim AL, Corbett JA. Double-stranded RNA inhibits ß-cell function and induces islet damage by stimulating ß-cell production of nitric oxide. J Biol Chem 1999 274 12531-12536
14. Liu D, Darville M, Eizirik DL. Double-stranded ribonucleic acid (RNA) Induces ß-cell fas messenger RNA expression and increases cytokine-induced ß-cell apoptosis. Endocrinology 2001 142 2593-2599
15. Scarim AL, Arnush M, Blair LA, et al. Mechanisms of ß-Cell death in response to double-stranded (ds) RNA and Interferon- dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol 2001 159 273-283
16. Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-meiated recognition of single stranded RNA. Science 2004 303 1529-1531
17. Guvener M, Pasaoglu I, Demircin M, et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002 49 (5) 531-537
18. Ocak S, Duran N, Kaya H, et al. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. Int J Clin Pract 2006 60 (6) 670-674 (Pubitemid 43811646)
19. Hiroki K, Osamu T, Shintaro S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006 441 (7089) 101-105
20. Kang D, Gopalkrishnan RV, Wu Q, et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 2002 99 (2) 637-642
21. Hiscott J. Triggering the innate antiviral response through IRF-3 Activation. J Biol Chem 2007 282 (21) 15325-15329
22. Yeow WS, Au WC, Lowther WJ, et al. Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cells. J Virol 2001 75 (6) 3021-3027
23. Gitlin L, Barchet W, Gilfillan S, et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006 103 (22) 8459-8464
24. Kocic G, Bjelakovic G, Saranac Lj, et al. Possible impact of plasma RNase activity on immune dysfunction in juvenile diabetes mellitus. Pediatr Diab 2005 6 155-160
25. Kocic G, Bjelakovic G, Saranac Lj, et al. Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients. Diab Res Clin Pract 2008 79 204-213
26. Navarro-Gonzales JA, Garcia-Benayas C, Arenos J. Semiautomated measurement of nitrate in biological fluids. Clin Chem 1998 44 679-682
27. Oliver CN, Ahn B, Moerenman EJ, et al. Age-related changes in oxidized proteins. J Biol Chem 1987 262 5488-5491
28. Tien M, Berlett BS, Levine RL, et al. Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentartion: pH dependence of carbonyl formation, tyrosine nitration and methionine oxidation. Proc Natl Acad Sci USA 1999 96 7809-7814
29. Baker JR, Zyzak DV, Thorpe SR, et al. Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction. Clin Chem 1993 39 2460-2465
30. Kizaki H, Sakurada T. Simple micro-assay methods for enzymes of purine metabolism. J Lab Clin Med 1977 89 1135-1144
31. Pavlovic V, Cekic S, Kociæ G, et al. Effect of monosodium glutamate on apoptosis and Bcl-2/Bax protein level in rat thymocyte culture. Physiol Res 2007 56 619-626
32. Ceriello A. Oxidative stress and diabetes-associated complications. Endocr Pract 2006 12 (Suppl 1) 60-62
33. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a causal antioxidant therapy. Diab Care 2003 26 1589-1596
34. Tak PP, Gary S, Firestein GS. NF-B: a key role in inflammatory diseases. Clin Invest 2001 107 (1) 7-11
35. Hibbs JB. Synthesis of nitric oxide from l-arginine a recently discovered pathway induced by cytokines with antitumor and antimicrobial activity. Res Immunol 1991 142 565-569
36. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991 43 109-142
37. Butler AR, Williams DHL. The physiological role of nitric oxide. J Chem Soc Rev 1993 22 233-241
38. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovas Dis 1995 38 105-128
39. Huie RE, Padmaja S. The reaction of NO with superoxide Free Radic. Res Commun 1993 18 195-199
40. Pavlovic D, Kocic R, Kocic G, et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2000 2 251-256
41. Lapolla A, Piarulli F, Sartore G, et al. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diab Care 2007 30 670-676
42. Kocic G, Bjelakovic G, Pavlovic R, et al. Nitrosative stress and its relation to paramethers of diabetic control in the early stages of Type 1 diabetes. Diab Metab 2003 29 4S210
43. Esposito K, Ciotola M, Schisano B, et al. Oxidative stress in the metabolic syndromeOxidative stress in the metabolic syndrome. J Endocrinol Invest 2006 29 791-795
44. Stamler JS, Simon DI, Osbourne JA, et al. S -Nitrosylation of proteins with nitric oxide synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992 89 444-448
45. Cote CG, Yu FS, Zulueta JJ, et al. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol 1996 271 (Lung Cell Mol Physiol 15) L869-L874
46. White CR, darley-Usmar V, Berrington WR, et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 1996 93 8745-8749
47. Connelly L, Jacobs AT, Palacios-Callender M, et al. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 2003 278 26480-26487
48. Connelly L, Palacios-Callender M, Ameixa C, et al. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 2001 166 3873-3881
49. Ahn KS, Sethi G, Aggarwal BB. Nuclear factor-kappa B: from clone to clinic. Curr Mol Med 2007 7 619-637
50. Reimer T, Brcic M, Schweizer M, et al. Poly(I:C) and LPS induce distinct IRF3 and NF-B signaling during type-I IFN and TNF responses in human macrophages. J Leukocyte Biol 2008 83 1249-1257
51. Desco MC, Miguel Asensi M, Márquez R, et al. 1 Xanthine oxidase is involved in free radical production in type 1 diabetes. Protection by Allopurinol Diabetes 2002 51 1118-1124
52. Ghezzi P, Bianchi PM, Mantovani A, et al. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun 1984 119 144-149
53. Pacher P, Nivorozhkin A, Szabo S. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006 58 87-114
54. Lu LL, Puri M, Horvath CM, et al. Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of B Kinase (IKKe)/TBK1. J Biol Chem 2008 283 (21) 14269-14276
55. Devaraj SG, Wang N, Chen Z, et al. Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus. J Biol Chem 2007 282 (44) 32208-32221